Terms: = Skin cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
13 results:
1. Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness.
Monti M; Benerini Gatta L; Bugatti M; Pezzali I; Picinoli S; Manfredi M; Lavazza A; Vanella VV; De Giorgis V; Zanatta L; Missale F; Lonardi S; Zanetti B; Bozzoni G; Cadei M; Abate A; Vergani B; Balzarini P; Battocchio S; Facco C; Turri-Zanoni M; Castelnuovo P; Nicolai P; Fonsatti E; Leone BE; Marengo E; Sigala S; Ronca R; Perego M; Lombardi D; Vermi W
J Transl Med; 2024 Jan; 22(1):35. PubMed ID: 38191367
[TBL] [Abstract] [Full Text] [Related]
2. Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma.
Ke G; Cheng N; Sun H; Meng X; Xu L
BMC Med Genomics; 2023 Jul; 16(1):160. PubMed ID: 37422626
[TBL] [Abstract] [Full Text] [Related]
3. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
[TBL] [Abstract] [Full Text] [Related]
4.
Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Lobmaier I; Micci F; Heim S
Cancer Genomics Proteomics; 2020; 17(3):237-248. PubMed ID: 32345665
[TBL] [Abstract] [Full Text] [Related]
5. Merkel Cell Polyomavirus Downregulates N-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration.
Gupta P; Shahzad N; Harold A; Shuda M; Venuti A; Romero-Medina MC; Pacini L; Brault L; Robitaille A; Taverniti V; Hernandez-Vargas H; Durand G; Le Calvez-Kelm F; Gheit T; Accardi R; Tommasino M
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694959
[TBL] [Abstract] [Full Text] [Related]
6. Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF-1β and NDRG-1.
Ercin ME; Bozdoğan Ö; Çavuşoğlu T; Bozdoğan N; Atasoy P; Koçak M
Balkan Med J; 2019 Dec; 37(1):15-23. PubMed ID: 31594284
[TBL] [Abstract] [Full Text] [Related]
7. Metastasis suppressor proteins in cutaneous squamous cell carcinoma.
Bozdogan O; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N; Atasoy P; Yulug IG
Pathol Res Pract; 2016 Jul; 212(7):608-15. PubMed ID: 27215390
[TBL] [Abstract] [Full Text] [Related]
8. Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma.
Bozdogan O; Yulug IG; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N
Int J Dermatol; 2015 Aug; 54(8):905-15. PubMed ID: 25428551
[TBL] [Abstract] [Full Text] [Related]
9. An immobilized antibody targeting N-cadherin facilitates spread of N-cadherin-positive tumour cells.
Maes D; Bracke M; Ost P
Anticancer Res; 2012 Nov; 32(11):4755-7. PubMed ID: 23155239
[TBL] [Abstract] [Full Text] [Related]
10. Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate.
Okudaira N; Goto M; Yanobu-Takanashi R; Tamura M; An A; Abe Y; Kano S; Hagiwara S; Ishizaka Y; Okamura T
Cancer Sci; 2011 Nov; 102(11):2000-6. PubMed ID: 21827582
[TBL] [Abstract] [Full Text] [Related]
11. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.
Chen Y; Zhu X; Zhang X; Liu B; Huang L
Mol Ther; 2010 Sep; 18(9):1650-6. PubMed ID: 20606648
[TBL] [Abstract] [Full Text] [Related]
12. Identification of dysregulated genes in cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Manning K; O'Currain E; Schneider S; Sterry W; Stockfleth E; Nindl I
Oncol Rep; 2006 Sep; 16(3):513-9. PubMed ID: 16865251
[TBL] [Abstract] [Full Text] [Related]
13. CT simulator: a new 3-D planning and simulating system for radiotherapy: Part 2. Clinical application.
Nagata Y; Nishidai T; Abe M; Takahashi M; Okajima K; Yamaoka N; Ishihara H; Kubo Y; Ohta H; Kazusa C
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):505-13. PubMed ID: 2318684
[TBL] [Abstract] [Full Text] [Related]
